<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>EMCYT- estramustine phosphate sodium capsule </strong><br>Pharmacia and Upjohn Company<br></p></div>
<h1>Emcyt<span class="Sup">®</span><br> estramustine phosphate sodium<br>capsules</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="DLDE"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Estramustine phosphate sodium, an antineoplastic agent, is an off-white powder readily soluble in water. EMCYT Capsules are white and opaque, each containing estramustine phosphate sodium as the disodium salt monohydrate equivalent to 140 mg estramustine phosphate, for oral administration. Each capsule also contains magnesium stearate, silicon dioxide, sodium lauryl sulfate, and talc. Gelatin capsule shells contain the following pigment: titanium dioxide.</p>
<p>Chemically, estramustine phosphate sodium is estra-1,3,5(10)-triene-3,17-diol(17β)-,3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), disodium salt, monohydrate. It is also referred to as estradiol 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate), disodium salt, monohydrate. Estramustine phosphate sodium has an empiric formula of C<span class="Sub">23</span>H<span class="Sub">30</span>Cl<span class="Sub">2</span>NNa<span class="Sub">2</span>O<span class="Sub">6</span>P•H<span class="Sub">2</span>O, a calculated molecular weight of 582.4, and the following structural formula:</p>
<div class="Figure"><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1&amp;name=emcyt-01.jpg"></div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Estramustine phosphate (Figure 1) is a molecule combining estradiol and nornitrogen mustard by a carbamate link. The molecule is phosphorylated to make it water soluble.</p>
<div class="Figure"><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1&amp;name=emcyt-02.jpg"></div>
<p>Estramustine phosphate taken orally is readily dephosphorylated during absorption, and the major metabolites in plasma are estramustine (Figure 2), the estrone analog (Figure 3), estradiol, and estrone.</p>
<div class="Figure"><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1&amp;name=emcyt-03.jpg"></div>
<div class="Figure"><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1&amp;name=emcyt-04.jpg"></div>
<p>Prolonged treatment with estramustine phosphate produces elevated total plasma concentrations of estradiol that <span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">fall</span> within ranges similar to the elevated estradiol levels found in prostatic cancer patients given conventional estradiol therapy. Estrogenic effects, as demonstrated by changes in circulating levels of steroids and pituitary hormones, are similar in patients treated with either estramustine phosphate or conventional estradiol.</p>
<p>The metabolic urinary patterns of the estradiol moiety of estramustine phosphate and estradiol itself are very similar, although the metabolites derived from estramustine phosphate are excreted at a slower rate.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">EMCYT Capsules are indicated in the palliative treatment of patients with metastatic and/or progressive carcinoma of the prostate.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">EMCYT Capsules should not be used in patients with any of the following conditions:</p>
<dl>
<dt>1)</dt>
<dd>Known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to either estradiol or to nitrogen mustard.</dd>
<dt>2)</dt>
<dd>Active <span class="product-label-link" type="condition" conceptid="320741" conceptname="Thrombophlebitis">thrombophlebitis</span> or thromboembolic disorders, except in those cases where the actual tumor <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">mass</span> is the cause of the thromboembolic phenomenon and the physician feels the benefits of therapy may outweigh the risks.</dd>
</dl>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">It has been shown that there is an increased risk of <span class="product-label-link" type="condition" conceptid="4130722" conceptname="Thrombosis">thrombosis</span>, including fatal and nonfatal <span class="product-label-link" type="condition" conceptid="4329847" conceptname="Myocardial infarction">myocardial infarction</span>, in men receiving estrogens for prostatic cancer. EMCYT Capsules should be used with caution in patients with a history of <span class="product-label-link" type="condition" conceptid="320741" conceptname="Thrombophlebitis">thrombophlebitis</span>, <span class="product-label-link" type="condition" conceptid="4130722" conceptname="Thrombosis">thrombosis</span>, or thromboembolic disorders, especially if they were associated with estrogen therapy. Caution should also be used in patients with cerebral vascular or <span class="product-label-link" type="condition" conceptid="317576" conceptname="Coronary arteriosclerosis">coronary artery disease</span>.</p>
<p>Glucose Tolerance—Because glucose tolerance may be decreased, diabetic patients should be carefully observed while receiving EMCYT.</p>
<p>Elevated Blood Pressure—Because <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span> may occur, blood pressure should be monitored periodically.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4125002" conceptname="Idiopathic fluid retention">Fluid Retention</span>. Exacerbation of preexisting or incipient <span class="product-label-link" type="condition" conceptid="4094513" conceptname="Ankle edema">peripheral edema</span> or congestive heart disease has been seen in some patients receiving therapy with EMCYT Capsules. Other conditions which might be influenced by <span class="product-label-link" type="condition" conceptid="4125002" conceptname="Idiopathic fluid retention">fluid retention</span>, such as <span class="product-label-link" type="condition" conceptid="380378" conceptname="Epilepsy">epilepsy</span>, <span class="product-label-link" type="condition" conceptid="318736" conceptname="Migraine">migraine</span>, or renal dysfunction, require careful observation.</p>
<p>EMCYT may be poorly metabolized in patients with <span class="product-label-link" type="condition" conceptid="4326594" conceptname="Abnormal liver function">impaired liver function</span> and should be administered with caution in such patients.</p>
<p>Because EMCYT may influence the metabolism of calcium and phosphorus, it should be used with caution in patients with metabolic bone diseases that are associated with <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span> or in patients with <span class="product-label-link" type="condition" conceptid="192359" conceptname="Renal failure syndrome">renal insufficiency</span>. Patients with prostate cancer and osteoblastic <span class="product-label-link" type="condition" conceptid="432851" conceptname="Secondary malignant neoplastic disease">metastases</span> are at risk for <span class="product-label-link" type="condition" conceptid="435510" conceptname="Hypocalcemia">hypocalcemia</span> and should have calcium levels closely monitored.</p>
<p><span class="product-label-link" type="condition" conceptid="4168447" conceptname="Gynecomastia">Gynecomastia</span> and <span class="product-label-link" type="condition" conceptid="4216771" conceptname="Impotence">impotence</span> are known estrogenic effects.</p>
<p><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergic reactions</span> and <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span> at times involving the airway have been reported.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-6.2"></a><p></p>
<h2>Information for the Patient</h2>
<p class="First">Because of the possibility of mutagenic effects, patients should be advised to use contraceptive measures.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="section-6.3"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">Certain endocrine and liver function tests may be affected by estrogen-containing drugs. EMCYT may depress testosterone levels. Abnormalities of hepatic enzymes and of bilirubin have occurred in patients receiving EMCYT. Such tests should be done at appropriate intervals during therapy and repeated after the drug has been withdrawn for two months.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-6.4"></a><p></p>
<h2>Food/Drug Interaction</h2>
<p class="First">Milk, milk products, and calcium-rich foods or drugs may impair the absorption of EMCYT.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-6.5"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Long-term continuous administration of estrogens in certain animal species increases the frequency of carcinomas of the breast and liver. Compounds structurally similar to EMCYT are carcinogenic in mice. Carcinogenic studies of EMCYT have not been conducted in man. Although testing by the Ames method failed to demonstrate mutagenicity for estramustine phosphate sodium, it is known that both estradiol and nitrogen mustard are mutagenic. For this reason and because some patients who had been impotent while on estrogen therapy have regained potency while taking EMCYT, the patient should be advised to use contraceptive measures.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">In a randomized, double-blind trial comparing therapy with EMCYT Capsules in 93 patients (11.5 to 15.9 mg/kg/day) or diethylstilbestrol (DES) in 93 patients (3.0 mg/day), the following adverse effects were reported:</p>
<table width="80%">
<col align="left" valign="middle" width="50%">
<col align="center" valign="middle" width="25%">
<col align="center" valign="middle" width="25%">
<thead><tr class="First Last">
<th align="left"></th>
<th align="center">EMCYT<br>n=93</th>
<th align="center">DES<br>n=93</th>
</tr></thead>
<tbody>
<tr class="First">
<td align="left">CARDIOVASCULAR-RESPIRATORY</td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="321042" conceptname="Cardiac arrest">Cardiac Arrest</span></td>
<td align="center">0</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="381316" conceptname="Cerebrovascular accident">Cerebrovascular Accident</span></td>
<td align="center">2</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4329847" conceptname="Myocardial infarction">Myocardial Infarction</span></td>
<td align="center">3</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="320741" conceptname="Thrombophlebitis">Thrombophlebitis</span></td>
<td align="center">3</td>
<td align="center">7</td>
</tr>
<tr>
<td align="left">  Pulmonary Emboli</td>
<td align="center">2</td>
<td align="center">5</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="319835" conceptname="Congestive heart failure">Congestive Heart Failure</span></td>
<td align="center">3</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">Edema</span></td>
<td align="center">19</td>
<td align="center">17</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">Dyspnea</span></td>
<td align="center">11</td>
<td align="center">3</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="75635" conceptname="Cramp">Leg Cramps</span></td>
<td align="center">8</td>
<td align="center">11</td>
</tr>
<tr>
<td align="left">  Upper Respiratory Discharge</td>
<td align="center">1</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4142495" conceptname="Hypophonia">Hoarseness</span></td>
<td align="center">1</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">GASTROINTESTINAL</td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span></td>
<td align="center">15</td>
<td align="center">8</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">Diarrhea</span></td>
<td align="center">12</td>
<td align="center">11</td>
</tr>
<tr>
<td align="left">  Minor <span class="product-label-link" type="condition" conceptid="4183041" conceptname="Abdominal discomfort">Gastrointestinal Upset</span></td>
<td align="center">11</td>
<td align="center">6</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">Anorexia</span></td>
<td align="center">4</td>
<td align="center">3</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4012503" conceptname="Excessive upper gastrointestinal gas">Flatulence</span></td>
<td align="center">2</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span></td>
<td align="center">1</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="192671" conceptname="Gastrointestinal hemorrhage">Gastrointestinal Bleeding</span></td>
<td align="center">1</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  Burning Throat</td>
<td align="center">1</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4241197" conceptname="Thirst">Thirst</span></td>
<td align="center">1</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">INTEGUMENTARY</td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">Rash</span></td>
<td align="center">1</td>
<td align="center">4</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">Pruritus</span></td>
<td align="center">2</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">Dry Skin</span></td>
<td align="center">2</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  Pigment Changes</td>
<td align="center">0</td>
<td align="center">3</td>
</tr>
<tr>
<td align="left">  Easy <span class="product-label-link" type="condition" conceptid="441737" conceptname="Contusion">Bruising</span></td>
<td align="center">3</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">Flushing</span></td>
<td align="center">1</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4181178" conceptname="Night sweats">Night Sweats</span></td>
<td align="center">0</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">  Fingertip—<span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">Peeling</span> Skin</td>
<td align="center">1</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  Thinning Hair</td>
<td align="center">1</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">BREAST CHANGES</td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4082445" conceptname="Tenderness">Tenderness</span></td>
<td align="center">66</td>
<td align="center">64</td>
</tr>
<tr>
<td align="left">  Enlargement</td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">    Mild</td>
<td align="center">60</td>
<td align="center">54</td>
</tr>
<tr>
<td align="left">    Moderate</td>
<td align="center">10</td>
<td align="center">16</td>
</tr>
<tr>
<td align="left">    Marked</td>
<td align="center">0</td>
<td align="center">5</td>
</tr>
<tr>
<td align="left">MISCELLANEOUS</td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4061577" conceptname="Lethargy">Lethargy</span> Alone</td>
<td align="center">4</td>
<td align="center">3</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">Depression</span></td>
<td align="center">0</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4078201" conceptname="Mood swings">Emotional Lability</span></td>
<td align="center">2</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">Insomnia</span></td>
<td align="center">3</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span></td>
<td align="center">1</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">Anxiety</span></td>
<td align="center">1</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">Chest Pain</span></td>
<td align="center">1</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4113666" conceptname="Menopausal flushing">Hot Flashes</span></td>
<td align="center">0</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="4201702" conceptname="Sore eye">Pain in Eyes</span></td>
<td align="center">0</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">  Tearing of Eyes</td>
<td align="center">1</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">  <span class="product-label-link" type="condition" conceptid="377575" conceptname="Tinnitus">Tinnitus</span></td>
<td align="center">0</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">LABORATORY ABNORMALITIES</td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">  Hematologic</td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">    <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">Leukopenia</span></td>
<td align="center">4</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">    <span class="product-label-link" type="condition" conceptid="441264" conceptname="Primary thrombocytopenia">Thrombopenia</span></td>
<td align="center">1</td>
<td align="center">2</td>
</tr>
<tr>
<td align="left">  Hepatic</td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr>
<td align="left">    Bilirubin Alone</td>
<td align="center">1</td>
<td align="center">5</td>
</tr>
<tr>
<td align="left">    Bilirubin and LDH</td>
<td align="center">0</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">    Bilirubin and <span class="product-label-link" type="condition" conceptid="4094657" conceptname="Aspartate aminotransferase">SGOT</span></td>
<td align="center">2</td>
<td align="center">1</td>
</tr>
<tr>
<td align="left">    Bilirubin, LDH and <span class="product-label-link" type="condition" conceptid="4094657" conceptname="Aspartate aminotransferase">SGOT</span></td>
<td align="center">2</td>
<td align="center">0</td>
</tr>
<tr>
<td align="left">    LDH and/or <span class="product-label-link" type="condition" conceptid="4094657" conceptname="Aspartate aminotransferase">SGOT</span></td>
<td align="center">31</td>
<td align="center">28</td>
</tr>
<tr>
<td align="left">  Miscellaneous</td>
<td align="center"></td>
<td align="center"></td>
</tr>
<tr class="Last">
<td align="left">    Hypercalcemia—Transient</td>
<td align="center">0</td>
<td align="center">1</td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">Although there has been no experience with overdosage to date, it is reasonable to expect that such episodes may produce pronounced manifestations of the known adverse reactions. In the event of overdosage, the gastric contents should be evacuated by gastric lavage and symptomatic therapy should be initiated. Hematologic and hepatic parameters should be monitored for at least 6 weeks after overdosage of EMCYT Capsules.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">The recommended daily dose is 14 mg per kg of body weight (ie, one 140 mg capsule for each 10 kg or 22 lb of body weight), given in 3 or 4 divided doses. Most patients in studies in the United States have been treated at a dosage range of 10 to 16 mg per kg per day.</p>
<p>Patients should be instructed to take EMCYT Capsules at least 1 hour before or 2 hours after meals. EMCYT should be swallowed with water. Milk, milk products, and calcium-rich foods or drugs (such as calcium-containing antacids) must not be taken simultaneously with EMCYT.</p>
<p>Patients should be treated for 30 to 90 days before the physician determines the possible benefits of continued therapy. Therapy should be continued as long as the favorable response lasts. Some patients have been maintained on therapy for more than 3 years at doses ranging from 10 to 16 mg per kg of body weight per day.</p>
<p>Procedures for proper handling and disposal of anticancer drugs should be considered. Several guidelines on this subject have been published.<span class="Sup">1–8</span> There is no general agreement that all of the procedures recommended in the guidelines are necessary or appropriate.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">White opaque capsules, each containing estramustine phosphate sodium as the disodium salt monohydrate equivalent to 140 mg estramustine phosphate—bottle of 100 (NDC 0013-0132-02).</p>
<p><span class="Bold">NOTE</span></p>
<p>EMCYT Capsules should be stored in the refrigerator at 36° to 46°F (2° to 8°C).</p>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="section-11"></a><p></p>
<h1>REFERENCES</h1>
<ol>
<li>Recommendations for the Safe Handling of Parenteral Antineoplastic Drugs. NIH Publication No. 83–2621. For sale by the Superintendent of Documents, U.S. Government Printing Office, Washington, DC, 20402.</li>
<li>AMA Council Report, Guidelines for Handling Parenteral Antineoplastics, JAMA. 1985; 253 (11):1590–1592.</li>
<li>National Study Commission on Cytotoxic Exposure-Recommendations for Handling Cytotoxic Agents. Available from Louis P. Jeffrey, Sc.D., Chairman, National Study Commission on Cytotoxic Exposure, Massachusetts College of Pharmacy and Allied Health Sciences, 179 Longwood Avenue, Boston, Massachusetts 02115.</li>
<li>Clinical Oncological Society of Australia. Guidelines and Recommendations for Safe Handling of Antineoplastic Agents. Med J Australia. 1983; 1:426–428.</li>
<li>Jones RB, et al. Safe Handling of Chemotherapeutic Agents: A Report from the Mount Sinai Medical Center. CA-A Cancer Journal for Clinicians. 1983; (Sept/Oct) 258–263.</li>
<li>American Society of Hospital Pharmacists Technical Assistance Bulletin on Handling Cytotoxic and Hazardous Drugs. Am J Hosp Pharm. 1990; 47:1033–1049.</li>
<li>OSHA Work-Practice Guidelines for Personnel Dealing with Cytotoxic (Antineoplastic) Drugs. Am J Hosp Pharm. 1986; 43:1193–1204.</li>
<li>ONS Clinical Practice Committee. Cancer Chemotherapy Guidelines and Recommendations for Practice. Pittsburgh, Pa: Oncology Nursing Society; 1999:32–41.</li>
</ol>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-12"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx only</span></p>
<p><img alt="Logo" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1&amp;name=emcyt-05.jpg"></p>
<p>LAB-0088-4.0<br>June 2007</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-13"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 140 mg Capsule Bottle Label</h1>
<p class="First">NDC 0013-0132-02<br><span class="Bold">100 Capsules<br>Rx only</span></p>
<p><span class="Bold">Emcyt</span><span class="Sup">®</span><br>estramustine phosphate<br>sodium capsules</p>
<p><span class="Bold">140 mg*</span></p>
<p><span class="Bold">Store in refrigerator at 36° to 46°F (2° to 8°C).</span></p>
<p><span class="Bold Italics">Pfizer</span><br><span class="Italics">Distributed by</span><br><span class="Bold">Pharmacia &amp; Upjohn Co</span><br>Division of Pfizer Inc, NY, NY 10017</p>
<div class="Figure"><img alt="PRINCIPAL DISPLAY PANEL - 140 mg Capsule Bottle Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1&amp;name=emcyt-06.jpg"></div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-14"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 140 mg Capsule Bottle Carton</h1>
<p class="First">NDC 0013-0132-02</p>
<p><span class="Bold">100 Capsules<br>Rx only</span></p>
<p><span class="Bold">Emcyt</span><span class="Sup">®</span><br>estramustine phosphate<br>sodium capsules</p>
<p><span class="Bold">140 mg*</span></p>
<p><span class="Bold">Store in refrigerator at 36° to 46°F <br> (2° to 8°C).</span></p>
<p><span class="Bold Italics">Pfizer</span><br><span class="Italics">Distributed by</span><br><span class="Bold">Pharmacia &amp; Upjohn Co</span><br>Division of Pfizer Inc, NY, NY 10017</p>
<div class="Figure"><img alt="PRINCIPAL DISPLAY PANEL - 140 mg Capsule Bottle Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1&amp;name=emcyt-07.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>EMCYT 		
					</strong><br><span class="contentTableReg">estramustine phosphate sodium capsule</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0013-0132</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ESTRAMUSTINE PHOSPHATE SODIUM</strong> (ESTRAMUSTINE) </td>
<td class="formItem">ESTRAMUSTINE PHOSPHATE</td>
<td class="formItem">140 mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SILICON DIOXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM LAURYL SULFATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>TALC</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>TITANIUM DIOXIDE</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE (opaque) </td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">CAPSULE</td>
<td class="formLabel">Size</td>
<td class="formItem">19mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">PHARMACIA;AND;UPJOHN;EMCYT;140MG</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0013-0132-02</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA018045</td>
<td class="formItem">01/01/1992</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Pharmacia and Upjohn Company
							(829076566)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Pfizer Cork Limited</td>
<td class="formItem"></td>
<td class="formItem">988786778</td>
<td class="formItem">API MANUFACTURE(0013-0132)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Pfizer Italia S.r.l.</td>
<td class="formItem"></td>
<td class="formItem">431227388</td>
<td class="formItem">MANUFACTURE(0013-0132), PACK(0013-0132)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Valdepharm</td>
<td class="formItem"></td>
<td class="formItem">260128560</td>
<td class="formItem">API MANUFACTURE(0013-0132)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Excella GmbH</td>
<td class="formItem"></td>
<td class="formItem">329809800</td>
<td class="formItem">API MANUFACTURE(0013-0132)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 6/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>4fa4f7fb-b11d-4772-a876-562a785d92e3</div>
<div>Set id: a9b01bc6-95ac-46f9-befa-d845a74d53c1</div>
<div>Version: 8</div>
<div>Effective Time: 20140617</div>
</div>
</div> <div class="DistributorName">Pharmacia and Upjohn Company</div></p>
</body></html>
